Person

Michelle Kumbier

Director, Abbott Laboratories

Current S&P 500 boards
2
Current roles
2
Open-market buys
$405K
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 23, 2021ABTBuy2,040$122.50$250K
Feb 23, 2021TDYBuy127$387.00$49K
Feb 22, 2021TDYBuy193$404.91$78K
Feb 22, 2021TDYBuy68$405.50$28K

SEC reporting-owner ID (CIK) 1640036 · all filings on EDGAR

Michelle Kumbier (ABT, TDY) | USBoard